The Capacity of Equity Anomalies
Every practitioner knows the pitch: a strategy with a Sharpe ratio of 1 and a t-stat above 2.0 must be a great business. But as Avramov, Bongaerts, Crego, and Kvaerner argue in their new paper, alpha tells you the return per dollar, not the size of the opportunity. The capacity of equity anomalies—the amount of capital a strategy can deploy before transaction costs eliminate its market-hedged return above cash—is a separate dimension that most of the literature ignores. Using stock-day estimates of spreads, price impact, and liquidity replenishment from NYSE TAQ data (2010–2023), the authors compute capacity for 35 characteristic-based anomalies and long–short factors and ask a simple question: are the anomalies that look biggest in return space also the biggest in deployable capital? For anyone allocating real money, the answer is no.